GlassScriptPhysician profile
Luis Espinoza
NPI 1376646620
$7,881.19
in general payments reported to CMS, 2019-2025
19 companies · $2,650 in 2025
The $2,650 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $592 · 2021: $954 · 2022: $229 · 2023: $2,328 · 2024: $729 · 2025: $2,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,360 · Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,360.42 |
| Food and Beverage | $2,345.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,456.66 | 2025 | Solyx Sis System, Axonics |
| Axonics, INC. | $2,365.94 | 2021-2024 | Axonics, Bulkamid |
| Ethicon US, LLC | $1,356.25 | 2020-2025 | Vistaseal, Ultra Vac, Ethicon |
| Abbvie INC. | $920.54 | 2019-2024 | |
| Applied Medical Resources Corporation | $145.92 | 2020 | |
| Sumitomo Pharma America, INC. | $118.04 | 2024-2025 | Myfembree |
| Stryker Corporation | $90.12 | 2021 | |
| Medical Device Business Services, INC. | $88.02 | 2024 | Surgicel Nu-Knit |
| Pfizer INC. | $76.19 | 2020-2024 | |
| Duchesnay USA Incorporated | $58.36 | 2019 | |
| Medtronic USA, INC. | $44.51 | 2019-2020 | |
| Hologic Sales and Service, LLC | $36.01 | 2024 | Coolseal Generator, Acessa Provu System, Novasure |
| Heron Therapeutics, INC. | $29.71 | 2023-2025 | Zynrelef |
| Davol INC. | $18.14 | 2021 | |
| Inspire Medical Systems, INC. | $17.98 | 2024 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.92 | 2020 | |
| Lilly USA, LLC | $14.62 | 2025 | Zepbound, Mounjaro |
| Becton, Dickinson and Company | $13.78 | 2023 | Bd Onclarity |
| Urovant Sciences INC | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Espinoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.